These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2410280)

  • 21. Human hybridoma generation by hypo-osmolar electrofusion: characterization of human monoclonal antibodies to Schistosoma mansoni parasite antigens.
    Klock G; Wisnewski AV; el-Bassiouni EA; Ramadan MI; Gessner P; Zimmermann U; Kresina TF
    Hybridoma; 1992 Aug; 11(4):469-81. PubMed ID: 1398684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrofusion of cells: hybridoma production by electrofusion and polyethylene glycol.
    Hui SW; Stenger DA
    Methods Enzymol; 1993; 220():212-27. PubMed ID: 8350755
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell activation by CpG ODN leads to improved electrofusion in hybridoma production.
    Kato M; Sasamori E; Chiba T; Hanyu Y
    J Immunol Methods; 2011 Oct; 373(1-2):102-10. PubMed ID: 21878337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single-step technique for selecting and cloning hybridomas for monoclonal antibody production.
    Davis JM
    Methods Enzymol; 1986; 121():307-22. PubMed ID: 3487692
    [No Abstract]   [Full Text] [Related]  

  • 25. Methods of enhancing the frequency of antigen-specific hybridomas.
    Siraganian RP; Fox PC; Berenstein EH
    Methods Enzymol; 1983; 92():17-26. PubMed ID: 6855610
    [No Abstract]   [Full Text] [Related]  

  • 26. Development and characterization of monoclonal antibodies against human CD20 in Balb/c mice.
    Sepehr KS; Baradaran B; Majidi J; Abdolalizadeh J; Aghebati L; Shahneh FZ
    Hum Antibodies; 2012; 21(3-4):57-64. PubMed ID: 23549022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monoclonal antibodies against surface antigens of laryngeal carcinoma cells (author's transl)].
    Zenner HP
    Arch Otorhinolaryngol; 1981; 233(2):161-72. PubMed ID: 6172103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of mouse-human hybridoma as a useful fusion partner for the establishment of mouse-human-human hybridoma secreting anti-tetanus toxoid human monoclonal antibody of IgM or IgG class.
    Hirata Y; Sugawara I
    Microbiol Immunol; 1987; 31(3):231-45. PubMed ID: 3613992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hybridoma technologies for antibody production.
    Tomita M; Tsumoto K
    Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Production of antibodies against measles virus and HBs antigen by use of the mouse hybridoma technique (author's transl)].
    Togashi T; Kuwajima S; Takebayashi T; Itoh H; Kato T
    Uirusu; 1981 Dec; 31(2):145-52. PubMed ID: 7336577
    [No Abstract]   [Full Text] [Related]  

  • 31. [Generation and characteristics of hybridomas producing monoclonal antibodies to the surface antigen of hepatitis B virus].
    Kushch AA; Momot AM; Shumaĭ EP; Bukrinskaia AG; Anan'ev VA
    Vopr Virusol; 1987; 32(4):448-51. PubMed ID: 3318133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitated cell fusion for hybridoma production.
    Conrad MK; Lo MM
    Methods Enzymol; 1990; 184():641-53. PubMed ID: 2167431
    [No Abstract]   [Full Text] [Related]  

  • 33. Human X (mouse X human) hybridomas.
    Ostberg L
    Methods Enzymol; 1986; 121():228-34. PubMed ID: 3724462
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoclonal antibody to cytokeratin for use in routine histopathology.
    Makin CA; Bobrow LG; Bodmer WF
    J Clin Pathol; 1984 Sep; 37(9):975-83. PubMed ID: 6206100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surface-epitope masking: a strategy for the development of monoclonal antibodies specific for molecules expressed on the cell surface.
    Shen R; Su ZZ; Olsson CA; Goldstein NI; Fisher PB
    J Natl Cancer Inst; 1994 Jan; 86(2):91-8. PubMed ID: 7505832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and immunochemical characterization of a keratin-like antigen in epithelial tumors using mouse and human monoclonal antibodies.
    Ho MK; Geist C; Murray J; Kato K; DeLellis R; Wolfe H; Carney W; Rabin H; Durda P
    Cancer Res; 1988 Sep; 48(17):4969-75. PubMed ID: 2457434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High efficiency fusion procedure for producing monoclonal antibodies against weak immunogens.
    Lane RD; Crissman RS; Ginn S
    Methods Enzymol; 1986; 121():183-92. PubMed ID: 3724460
    [No Abstract]   [Full Text] [Related]  

  • 38. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The generation of monoclonal antibodies against human pancreatic exocrine cancer: a study of six different immunisation regimes.
    Grant AG; Harris PM; Heyderman E; Larkin SE; Pym B; Hermon-Taylor J
    Br J Cancer; 1985 Oct; 52(4):543-50. PubMed ID: 4063133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hybridomas specific for carbohydrates; synthetic human blood group antigens for the production, selection, and characterization of monoclonal typing reagents.
    Bundle DR; Gidney MA; Kassam N; Rahman AF
    J Immunol; 1982 Aug; 129(2):678-2. PubMed ID: 6177774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.